View Author
patient study population endoscopy disease incidence model cancer health group number prevalence surveillance effect pompe muscle difference barrett result esophagus mortality netherland score treatment modelled bo population .0001 choice death pompe disease bo population table van der ploeg burden enzyme replacement therapy ns patients trend range gi endoscopy respondent modelled breast cancer muscle strength aco incidence rates health gain response adenocarcinoma therapy estimate breast life years distress endoscopic surveillance percentage questionnaire physiotherapy baseline rotterdam intervention erasmus mc university utility scenario discomfort preference erasmu citation purposes position page number strength sumscore frequency endoscopic center symptom reuser aj outcome patient groups data problems analysis adult van doorn pa
9 Most Recent Publications
|
Enzyme replacement therapy and fatigue in adults with Pompe disease
(Article)
Güngör, D. Vries, J.M. de Plug, I. Ploeg, A.T. van der Brusse, E. Kruijshaar, M.E. Hop, W.C.J. Murawska, M. Berg, L.E.M. van den Reuser, A.J.J. Doorn, P.A. van Hagemans, M. |
2013-04-19
|
|
Effect of enzyme therapy and prognostic factors in 69 adults with Pompe disease: An open-label single-center study
(Article)
Vries, J.M. de Beek, N.A.M.E. van der Faber, C.G. Verschuuren, J.J. Kruijshaar, M.E. Reuser, A.J.J. Doorn, P.A. van Ploeg, A.T. van der Hop, W.C.J. Karstens, F.P. Wokke, J.H.J. Visser, M. de Engelen, B.G. van Kuks, J.B.M. Kooi, A.J. van der Notermans, N.C. |
2012-09-28
|
|
Physiotherapy management in late-onset Pompe disease: Clinical practice in 88 patients
(Article)
Favejee, M.M. Huisstede, B.M.A. Bussmann, J.B.J. Kruijshaar, M.E. Ploeg, A.T. van der |
2012-09-01
|
|
A labelled discrete choice experiment adds realism to the choices presented: preferences for surveillance tests for Barrett esophagus.
(Article)
Kruijshaar, M.E. Essink-Bot, M.L.E. Donkers, A.C.D. Looman, C.W.N. Siersema, P.D. Steyerberg, E.W. |
2009-07-02
|
|
Different perceptions of the burden of upper GI endoscopy: An empirical study in three patient groups
(Article)
Essink-Bot, M.L.E. Bac, D.J. Kruijshaar, M.E. Wismans, P.J. Borg, F. ter Steyerberg, E.W. Siersema, P.D. |
2007-10-01
|
|
Evidence-based guidelines, time-based health outcomes, and the Matthew effect
(Article)
Essink-Bot, M.L.E. Kruijshaar, M.E. Barendregt, J.J.M. Bonneux, L.G.A. |
2007-09-01
|
|
Modelling a population with Barrett's oesophagus from oesophageal adenocarcinoma incidence data
(Article)
Blankenstein, M. van Looman, C.W.N. Kruijshaar, M.E. Siersema, P.D. Kuipers, E.J. Bytzer, P. |
2007-02-28
|
|
Patients with Barrett's esophagus perceive their risk of developing esophageal adenocarcinoma as low
(Article)
Kruijshaar, M.E. Siersema, P.D. Janssens, A.C.J.W. Kerkhof, M. Steyerberg, E.W. Essink-Bot, M.L.E. |
2007-01-01
|
|
Estimating the prevalence of breast cancer using a disease model: data problems and trends
(Article)
Kruijshaar, M.E. Barendregt, J.J.M. Poll-Franse, L.V. van de |
2003-01-01
|
